| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |